Nanoparticle formulation of copper dithiocarbomate for the cancer treatment

The main aim of this project is to obtain and characterize of anticancer drug’s (nano-CuET) prototype for launching a clinical trial That means: 1. formulation and production development, preparation of a drug prototype 2. development and certification of necessary analytical methods 3. validation of the drug prototype in necessary animal models 4. completion of the drug master file for clinical batch certification